Healthcare / PharmaceuticalsUpdated 2026-05-10 22:07 UTC

PSX/CPHL stock hub

PSX/CPHL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PSX/CPHLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18.4B

Pakistan Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

PSX/CPHL

In the news

Latest news · PSX/CPHL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.2

P25 9.7P50 11.8P75 12.4

Trailing P/E16.8

P25 11.3P50 13.1P75 16.5

ROE13.3

P25 13.5P50 23.8P75 30.1

ROIC9.9

P25 11.2P50 16.7P75 31.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PSX/CPHL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

PKR

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Pakistan
Country code	PK
Employees	531
Employees Change	12%
Employees Change Percent	2.31
Enterprise value	PKR 21.7B
Exchange	Pakistan Stock Exchange
Financial currency	PKR
First seen	2026-05-10
Industry	Pharmaceuticals
Last refreshed	2026-05-10
Market cap	PKR 18.4B
Price	PKR 80.64
Price currency	PKR
Rev Per Employee	26,065,719.19x
Sector	Healthcare
Sic	2834
Symbol	psx/CPHL
Website	https://www.citipharma.com.pk

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.95%
EV Earnings	19.76x
EV/EBIT	10.39x
EV/EBITDA	9.54x
EV/FCF	-29.21x
EV/Sales	1.57x
FCF yield	-4.03%
Forward P/E	19.2x
P/B ratio	1.68x
P/E ratio	16.8x
P/S ratio	1.33x
PE Ratio3 Y	14.18x
PE Ratio5 Y	13.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.06%
EBITDA Margin	16.37%
Gross margin	18.5%
Gross Profit	PKR 2.6B
Gross Profit Growth	50.67%
Gross Profit Growth Q	6.95%
Gross Profit Growth3 Y	17.6%
Gross Profit Growth5 Y	27.44%
Net Income	PKR 1.1B
Net Income Growth	31.98%
Net Income Growth Q	24.98%
Net Income Growth3 Y	19.89%
Net Income Growth5 Y	29.96%
Pretax Margin	12.13%
Profit Margin	7.92%
Profit Per Employee	PKR 2.1M
ROA	8.02
Roa5y	7.65
ROCE	18.54
ROE	13.28
Roe5y	13.31
ROIC	9.93
Roic5y	18.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	12.41%
Cagr3y	58.03%
Div CAGR3	11.87%
EPS Growth	31.94
EPS Growth Q	26.04
EPS Growth3 Y	19.93
EPS Growth5 Y	19.63
Revenue Growth	6.68x
Revenue Growth Q	-7.67x
Revenue Growth3 Y	7.8x
Revenue Growth5 Y	21.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	PKR 0.85
Assets	PKR 18.9B
Cash	PKR 324.2M
Current Assets	PKR 10B
Current Liabilities	PKR 7.6B
Debt	PKR 3.6B
Debt EBITDA	PKR 1.57
Debt Equity	PKR 0.33
Debt FCF	PKR -4.81
Equity	PKR 11B
Interest Coverage	5.66
Liabilities	PKR 7.9B
Long Term Assets	PKR 8.9B
Long Term Liabilities	PKR 292.7M
Net Cash	PKR -3.2B
Net Cash By Market Cap	PKR -17.6
Net Debt EBITDA	PKR 1.43
Net Debt Equity	PKR 0.3
Tangible Book Value	PKR 11B
Tangible Book Value Per Share	PKR 48.11
WACC	6.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.31
Inventory Turnover	2.65
Net Working Capital	PKR 5.5B
Quick ratio	0.59
Working Capital	PKR 2.3B
Working Capital Turnover	PKR 6.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.07%
Dividend Growth	7.69%
Dividend Growth Years	4%
Dividend per share	PKR 3.5
Dividend Years	3
Dividend Yield	4.34%
Ex Div Date	2025-10-17
Last Dividend	PKR 3.5
Payout Frequency	Annual
Payout Ratio	72.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	12.4%
200-day SMA	85.92
3Y total return	294.8%
50-day SMA	77.48
50-day SMA vs 200-day SMA	50under200
All Time High	109.3
All Time High Change	-26.22%
All Time High Date	2025-02-11
All Time Low	19.07
All Time Low Change	322.86%
All Time Low Date	2023-09-01
ATR	3.51
Beta	0.44
Beta1y	1.34
Beta2y	0.71
Ch YTD	-4.68
High	81.45
High52	104.3
High52 Date	2025-09-12
High52ch	-22.65%
Low	79.1
Low52	60.5
Low52 Date	2025-05-09
Low52ch	33.29%
Ma50ch	4.08%
Price vs 200-day SMA	-6.14%
RSI	53.22
RSI Monthly	57.82
RSI Weekly	47.24
Sharpe ratio	0.63x
Sortino ratio	1.14
Total Return	4.41%
Tr YTD	-4.68
Tr1m	11.06%
Tr1w	8.07%
Tr3m	-7.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	PKR 2.1B
Operating Income Growth	61.27
Operating Income Growth Q	3.14
Operating Income Growth3 Y	17.95
Operating Income Growth5 Y	32.3
Operating margin	15.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	135,637,840%
Net Borrowing	548,535,275
Shares Insiders	38.66%
Shares Institutions	6.42%
Shares Out	228,461,200
Shares Qo Q	-0.36%
Shares Yo Y	-0.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	PKR -741.7M
Average Volume	2,957,593.85x
Bv Per Share	48.11
CAPEX	PKR -50.7M
Ch1m	11.06
Ch1w	8.07
Ch1y	8.17
Ch3m	-7.85
Ch3y	217.4
Ch6m	-2.38
Change	-0.99%
Change From Open	0.8
Close	81.45
Days Gap	-1.78
Depreciation Amortization	181,061,351
Dollar Volume	98,598,366.7
Earnings Date	2026-04-29
EBIT	PKR 2.1B
EBITDA	PKR 2.3B
EPS	PKR 4.8
F Score	4
FCF	PKR -741.7M
FCF EV Yield	-3.42x
FCF Per Share	PKR -3.25
Financing CF	-251,661,421
Fiscal Year End	June
Founded	2,012
Graham Number	72.08567
Graham Upside	-10.61
Income Tax	PKR 581.6M
Investing CF	36,316,348
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2021-10-18
Last Split Type	Forward
Lynch Fair Value	PKR 120
Lynch Upside	48.81
Ma150	83.83
Ma150ch	-3.81%
Ma20	80.39
Ma20ch	0.31%
Net CF	-906,308,869
Next Earnings Date	2026-05-13
Open	80
Payment Date	2025-11-05
Position In Range	65.53
Ppne	8,624,089,332
Price Date	2026-05-08
Price EBITDA	PKR 8.13
Ptbv Ratio	1.68
Relative Volume	0.41x
Revenue	13,840,896,889x
Tax By Revenue	4.2x
Tax Rate	34.66%
Tr6m	-2.38%
Volume	1,222,698

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

PSX/CPHL dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.3%

$3.50 annual per share

Payout ratio

+72.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

4 consecutive years of growth

Total shareholder yield

+4.4%

Next ex-dividend date: 2025-10-17

Performance

PSX/CPHL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PSX/CPHL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.4%

Share of float held by funds and institutions

Insider ownership

+38.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

PSX/CPHL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.2

Neutral momentum band

Price vs 200-day MA

-6.1%

50/200-day relationship not available

Beta (5Y)

0.44

Less volatile than the market

Sharpe ratio

0.63

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PSX/CPHL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current psx/CPHL stock rating?

psx/CPHL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full psx/CPHL analysis?

The full report lives at /stocks/psx/CPHL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for psx/CPHL?

The latest report frames psx/CPHL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the psx/CPHL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.